Avadel Pharmaceuticals PLC (NAS:AVDL)
$ 13.945 0.295 (2.16%) Market Cap: 1.34 Bil Enterprise Value: 1.24 Bil PE Ratio: 0 PB Ratio: 19.10 GF Score: 43/100

Q2 2019 Avadel Pharmaceuticals PLC Earnings Call Transcript

Aug 09, 2019 / 12:30PM GMT
Release Date Price: $1.95 (-11.36%)
Operator

Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Avadel Pharmaceuticals Second Quarter 2019 Financial Results Conference Call. (Operator Instructions)

I will now turn the call over to Mr. Mike Kanan, Chief Financial Officer of Avadel. You may begin.

Michael F. Kanan
Avadel Pharmaceuticals plc - Senior VP & CFO

Thank you, and good morning to everyone, and thanks for joining us on our conference call.

This morning, we issued our second quarter 2019 financial results news release. This release can be accessed on our website at www.avadel.com.

As a reminder, before we begin, the following presentation includes a number of matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. These risks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot